Olumuyiwa Paul, MD
Orthopedic Surgery · Glenn Dale, MDNPI 1730105297
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Amgen at 40.2% of the total. Reporting peaked in 2019 at $585 and has fallen 89.9% since, to $59 in 2025.
Across 85 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$530
- Zyla Life Sciences, Inc.$223
- Johnson & Johnson$107
- Pacira Pharmaceuticals Incorporated$86
- Stryker$55
- Kowa Pharmaceuticals America, Inc.$49
- plus $269 from 8 others
What the payments were for
- Food & beverage$1,29998%
- Education$202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 36 | $530 |
| Zyla Life Sciences, Inc. | 21 | $223 |
| Johnson & Johnson | 5 | $107 |
| Pacira Pharmaceuticals Incorporated | 4 | $86 |
| Stryker | 2 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Fidia Pharma USA Inc. | 3 | $49 |
| Electronic Waveform Lab, Inc. | 2 | $48 |
| Smith+Nephew | 2 | $47 |
| Bioventus LLC | 2 | $46 |
| Medical Device Business Services, Inc. | 2 | $31 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $13 |
How this compares
$1,319 in reported general payments places this provider in the 65th percentile of 24 orthopedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 191 | $9,550 |
| Celecoxib | 267 | $5,603 |
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 47 | $3,467 |
| Ec-NaproxenNaproxen | 25 | $1,606 |
| Pregabalin | 45 | $917 |
| Ibuprofen | 35 | $359 |
| Naproxen | 15 | $344 |
| Gabapentin | 33 | $294 |
| Meloxicam | 132 | $287 |
| Oxycodone Hcl | 25 | $131 |
| Methylprednisolone | 16 | $129 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $98 |
| Tramadol Hcl | 50 | $75 |
| Pantoprazole Sodium | 11 | $63 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Glenn Dale
- Christopher CannovaBethesda$1.6M
- Craig MillerBethesda$72K
- Jason KinneyBaltimore$22K
- Mark PetersonRockville$13K
- Akachimere UzosikeBaltimore$12K
- James MurphyGlen Burnie$2K
- Andrew SiekanowiczSilver Spring$2K
- Benjamin KnoxEaston$2K
- Mark PfaffElkton$1K
- Roy BandsAnnapolis$917
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.